\-\ Texto\\:\\ \ \(0\)\
\-\ there\\ is\\ an\\ area\\ of\\ palpable\\ concern\\ in\\ the\\ inferior\\ left\\ breast\\.\ \(0\)\
\-\ the\\ patient\\ was\\ referred\\ to\\ a\\ surgical\\ breast\\ oncologist\\.\\ \\ surgical\\ resection\\ was\\ offered\\,\\ but\\ the\\ patient\\ declined\\.\\ \\ the\\ patient\\ is\\ being\\ followed\\ clinically\\.\ \(0\)\
\-\ mammography\\ \\(fig\\ 1\\)\\ demonstrates\\ an\\ ovoid\\ mass\\ in\\ the\\ inferior\\ left\\ breast\\.\\ \\ left\\ breast\\ ultrasound\\ \\(fig\\ 2\\)\\ demonstrates\\ a\\ wider\\-than\\-tall\\ 1\\.8cm\\ ovoid\\ mass\\ with\\ macrolobulated\\ borders\\ and\\ echotexture\\ similar\\ to\\ surrounding\\ adipose\\ tissue\\.\ \(0\)\
\-\ pseudoangiomatous\\ stromal\\ hyperplasia\\ of\\ breast\ \(0\)\
\-\ fibroadenoma\ \(22\)\
\-\ infarcting\\ adenoma\\ or\\ lipoma\ \(0\)\
\-\ breast\\ cancer\ \(149\)\
\-\ pash\ \(0\)\
\-\ she\\ \\"felt\\ a\\ lump\\"\\ under\\ her\\ left\\ breast\\;\\ she\\ has\\ a\\ history\\ of\\ bilateral\\ reduction\\ mammoplasty\\ six\\ years\\ earlier\\ \\(without\\ complication\\)\\.\ \(0\)\
\-\ pash\\ is\\ an\\ uncommon\\ cause\\ of\\ an\\ enlarging\\ breast\\ mass\\ in\\ a\\ pre\\-menopausal\\ female\\.\\[1\\,2\\]\\ \\ pash\\ is\\ more\\ often\\ found\\ incidentally\\ on\\ breast\\ biopsy\\ or\\ for\\ biopsy\\ of\\ an\\ enlarging\\ area\\ of\\ asymmetrically\\ dense\\ breast\\ tissue\\.\\[3\\]\\ \\ as\\ this\\ case\\ demonstrates\\,\\ the\\ mass\\-like\\ form\\ of\\ pash\\ \\(\\‚\\Ä\\útumoral\\‚\\Ä\\ù\\ pash\\)\\ may\\ be\\ isoechoic\\ with\\,\\ or\\ hypoechoic\\ to\\,\\ surrounding\\ breast\\ tissue\\ and\\ may\\ be\\ difficult\\ to\\ identify\\ sonographically\\,\\ especially\\ in\\ the\\ setting\\ of\\ prior\\ reduction\\ mammoplasty\\.\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ pathologically\\,\\ pash\\ is\\ characterized\\ by\\ myofibroblasts\\ simulating\\ vascular\\ channels\\ in\\ dense\\ stromal\\ collagen\\ tissue\\.\\ \\ as\\ a\\ result\\,\\ pash\\ can\\ be\\ visually\\ similar\\ to\\ vascular\\ breast\\ lesions\\ \\(such\\ as\\ angiosarcoma\\)\\,\\ but\\ differentiation\\ is\\ is\\ usually\\ not\\ difficult\\ for\\ an\\ experienced\\ patholgist\\.\\[4\\]\\ \\ the\\ pathogenesis\\ of\\ pash\\ remains\\ uncertain\\,\\ but\\ aberrant\\ reactivation\\ of\\ myofibroblasts\\ to\\ endogenous\\ or\\ exogenous\\ hormones\\ is\\ likely\\ to\\ be\\ an\\ important\\ factor\\.\ \(0\)\
\-\ \\ \\ \\ surgical\\ management\\ usually\\ includes\\ simple\\ excision\\ for\\ enlarging\\ lesions\\.\\ \\ however\\,\\ disease\\ recurrence\\ can\\ occur\\ in\\ up\\ to\\ 10\\ \\‚\\Ä\\ì\\ 25\\%\\ of\\ cases\\.\\ \\ in\\ addition\\,\\ a\\ diffuse\\ form\\ of\\ pash\\ can\\ occur\\ and\\ often\\ presents\\ a\\ difficult\\ management\\ problem\\ that\\ may\\ necessitate\\ mastectomy\\.\\ \\ \\ to\\ date\\,\\ no\\ studies\\ have\\ been\\ performed\\ to\\ determine\\ whether\\ alternative\\ treatments\\ such\\ as\\ hormonal\\ treatment\\ or\\ cryotherapy\\ could\\ be\\ effective\\ in\\ treatment\\ of\\ pash\\.\ \(0\)\
\-\ discussion\\ of\\ radiologic\\-pathologic\\ concordance\\ is\\ important\\ after\\ biopsy\\,\\ and\\ a\\ diagnosis\\ of\\ pash\\ is\\ concordant\\ with\\ an\\ enlarging\\ breast\\ mass\\.\\ \\ while\\ surgical\\ excision\\ is\\ usually\\ recommended\\,\\ it\\ may\\ be\\ complicated\\ in\\ the\\ setting\\ of\\ prior\\ breast\\ surgery\\,\\ such\\ as\\ bilateral\\ reduction\\ mammoplasty\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ cohen\\ ma\\,\\ morris\\ ea\\,\\ rosen\\ pr\\,\\ dershaw\\ dd\\,\\ liberman\\ l\\,\\ abramson\\ af\\.\\ pseudoangiomatous\\ stromal\\ hyperplasia\\:\\ mammographic\\,\\ sonographic\\,\\ and\\ clinical\\ patterns\\.\\ radiology\\ 1996\\;\\ 198\\:\\ 117\\-120\\.\ \(0\)\
\-\ 2\\.\\ cyrlak\\ d\\,\\ carpenter\\ pm\\.\\ breast\\ imaging\\ case\\ of\\ the\\ day\\:\\ pseudoangiomatous\\ stromal\\ hyperplasia\\.\\ radiographics\\ 1999\\;\\ 19\\:\\ 1086\\-1088\\.\ \(0\)\
\-\ 3\\.\\ piccoli\\ cw\\,\\ feig\\ sa\\,\\ palazzo\\ jp\\.\\ developing\\ asymmetric\\ breast\\ tissue\\.\\ radiology\\ 1999\\;\\ 211\\:\\ 111\\-117\\.\ \(0\)\
\-\ 4\\.\\ powell\\ cm\\,\\ cranor\\ ml\\,\\ rosen\\ pp\\.\\ \\ pash\\:\\ a\\ mammary\\ stromal\\ tumor\\ with\\ myofibroblasic\\ differentiation\\.\\ am\\ j\\ surg\\ pathology\\.\\ 1995\\;\\ 19\\:\\ 270\\-277\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pash\\:\\ 0\\.20111448875969198\ \(0\)\
\-\ breast\\:\\ 0\\.09589529867165178\ \(0\)\
\-\ stromal\\:\\ 0\\.05056093975760473\ \(0\)\
\-\ pseudoangiomatous\\:\\ 0\\.050278622189922996\ \(0\)\
\-\ mammoplasty\\:\\ 0\\.03918027533219307\ \(0\)\
\-\ myofibroblasts\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ rosen\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ enlarging\\:\\ 0\\.03307688445104118\ \(0\)\
\-\ \\]\\:\\ 0\\.025504066551974226\ \(0\)\
\-\ \\[\\:\\ 0\\.025430472988271332\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.02401339299227228\ \(0\)\
\-\ reduction\\:\\ 0\\.022973536204474065\ \(0\)\
\-\ difficult\\:\\ 0\\.021332763928133106\ \(0\)\
\-\ fig\\:\\ 0\\.020110866537453753\ \(0\)\
\-\ tissue\\:\\ 0\\.019253053122172945\ \(0\)\
\-\ \\;\\:\\ 0\\.019253053122172945\ \(0\)\
\-\ 1999\\:\\ 0\\.01842291448826759\ \(0\)\
\-\ an\\:\\ 0\\.01797208919064228\ \(0\)\
\-\ ovoid\\:\\ 0\\.017888382356628086\ \(0\)\
\-\ differentiation\\:\\ 0\\.01731117318222503\ \(0\)\
\-\ biopsy\\:\\ 0\\.017291026092985325\ \(0\)\
\-\ \\:\\:\\ 0\\.017190491497956883\ \(0\)\
\-\ wider\\-than\\-tall\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ infarcting\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ pre\\-menopausal\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ patholgist\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ morris\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ dershaw\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ liberman\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ abramson\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 117\\-120\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ cyrlak\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ piccoli\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ feig\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ palazzo\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 111\\-117\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ powell\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ cranor\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ myofibroblasic\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ 270\\-277\\:\\ 0\\.01675954072997433\ \(0\)\
\-\ setting\\:\\ 0\\.016409538987210013\ \(0\)\
\-\ concordance\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ cohen\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ 1086\\-1088\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ cw\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ 211\\:\\ 0\\.015441770424727287\ \(0\)\
\-\ dense\\:\\ 0\\.015347509242794558\ \(0\)\
\-\ such\\:\\ 0\\.015235738345099918\ \(0\)\
\-\ form\\:\\ 0\\.015191014670575898\ \(0\)\
\-\ be\\:\\ 0\\.01503144551342885\ \(0\)\
\-\ 19\\:\\ 0\\.014982209508613486\ \(0\)\
\-\ usually\\:\\ 0\\.014799971029658323\ \(0\)\
\-\ as\\:\\ 0\\.01474423010525621\ \(0\)\
\-\ macrolobulated\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ cryotherapy\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ 198\\:\\ 0\\.014670924211593894\ \(0\)\
\-\ important\\:\\ 0\\.014596139473558645\ \(0\)\
\-\ may\\:\\ 0\\.014253447672229079\ \(0\)\
\-\ reactivation\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ endogenous\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ af\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ sa\\:\\ 0\\.014124000119480243\ \(0\)\
\-\ \\,\\:\\ 0\\.01389576381932844\ \(0\)\
\-\ radiology\\:\\ 0\\.013731983790455144\ \(0\)\
\-\ 1\\.8cm\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ necessitate\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ ea\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ pr\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ dd\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ carpenter\\:\\ 0\\.013699772835612923\ \(0\)\
\-\ surgical\\:\\ 0\\.013659481142596606\ \(0\)\
\-\ adipose\\:\\ 0\\.01335315390634685\ \(0\)\
\-\ visually\\:\\ 0\\.01335315390634685\ \(0\)\
\-\ concordant\\:\\ 0\\.01335315390634685\ \(0\)\
\-\ excision\\:\\ 0\\.013335554093404157\ \(0\)\
\-\ asymmetrically\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ radiologic\\-pathologic\\:\\ 0\\.013060091777397689\ \(0\)\
\-\ exogenous\\:\\ 0\\.012806229814233197\ \(0\)\
\-\ hormones\\:\\ 0\\.012806229814233197\ \(0\)\
\-\ similar\\:\\ 0\\.01274405558532657\ \(0\)\
\-\ channels\\:\\ 0\\.012582307693213456\ \(0\)\
\-\ 1\\,2\\:\\ 0\\.01238200253036588\ \(0\)\
\-\ simulating\\:\\ 0\\.01238200253036588\ \(0\)\
\-\ management\\:\\ 0\\.012260575830629814\ \(0\)\
\-\ occur\\:\\ 0\\.012190291364188359\ \(0\)\
\-\ oncologist\\:\\ 0\\.012035383601099806\ \(0\)\
\-\ tumoral\\:\\ 0\\.012035383601099806\ \(0\)\
\-\ is\\:\\ 0\\.011758932627817456\ \(0\)\
\-\ isoechoic\\:\\ 0\\.011742321472150645\ \(0\)\
\-\ mammographic\\:\\ 0\\.011742321472150645\ \(0\)\
\-\ hormonal\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ jp\\:\\ 0\\.011611156317232486\ \(0\)\
\-\ sonographically\\:\\ 0\\.011488459508986153\ \(0\)\
\-\ pm\\:\\ 0\\.011488459508986153\ \(0\)\
\-\ mammary\\:\\ 0\\.011488459508986153\ \(0\)\
\-\ mass\\-like\\:\\ 0\\.01137320357397392\ \(0\)\
\-\ ml\\:\\ 0\\.011264537387966414\ \(0\)\
\-\ declined\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ ma\\:\\ 0\\.011161747993916461\ \(0\)\
\-\ offered\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ alternative\\:\\ 0\\.011064232225118835\ \(0\)\
\-\ can\\:\\ 0\\.01105450010913918\ \(0\)\
\-\ inferior\\:\\ 0\\.011024016583114308\ \(0\)\
\-\ pathologically\\:\\ 0\\.010798525110337165\ \(0\)\
\-\ surrounding\\:\\ 0\\.010681236746634088\ \(0\)\
\-\ case\\:\\ 0\\.010662572811030061\ \(0\)\
\-\ vascular\\:\\ 0\\.010653244364728885\ \(0\)\
\-\ demonstrates\\:\\ 0\\.010646128526539084\ \(0\)\
\-\ pp\\:\\ 0\\.010565440847804213\ \(0\)\
\-\ but\\:\\ 0\\.010394505519202686\ \(0\)\
\-\ often\\:\\ 0\\.01036681957612035\ \(0\)\
\-\ patterns\\:\\ 0\\.01035783763114073\ \(0\)\
\-\ echotexture\\:\\ 0\\.010293386011985442\ \(0\)\
\-\ fibroadenoma\\:\\ 0\\.010293386011985442\ \(0\)\
\-\ area\\:\\ 0\\.010273141612677821\ \(0\)\
\-\ uncertain\\:\\ 0\\.010231047945782038\ \(0\)\
\-\ 1996\\:\\ 0\\.010170689203739109\ \(0\)\
\-\ 1995\\:\\ 0\\.010055433268726877\ \(0\)\
\-\ identify\\:\\ 0\\.009699517789471845\ \(0\)\
\-\ surg\\:\\ 0\\.009699517789471845\ \(0\)\
\-\ mastectomy\\:\\ 0\\.009653704953770208\ \(0\)\
\-\ radiographics\\:\\ 0\\.00952253979885205\ \(0\)\
\-\ or\\:\\ 0\\.009520178222088475\ \(0\)\
\-\ lump\\:\\ 0\\.00948075480509012\ \(0\)\
\-\ mammography\\:\\ 0\\.009439868483377262\ \(0\)\
\-\ treatments\\:\\ 0\\.009399842990605718\ \(0\)\
\-\ collagen\\:\\ 0\\.009247670542557167\ \(0\)\
\-\ effective\\:\\ 0\\.009247670542557167\ \(0\)\
\-\ aberrant\\:\\ 0\\.009141036575539975\ \(0\)\
\-\ she\\:\\ 0\\.009120859853437918\ \(0\)\
\-\ borders\\:\\ 0\\.009040067325893686\ \(0\)\
\-\ mass\\:\\ 0\\.009037726288574636\ \(0\)\
\-\ problem\\:\\ 0\\.008882858740636816\ \(0\)\
\-\ whether\\:\\ 0\\.00873766296347983\ \(0\)\
\-\ lesions\\:\\ 0\\.008697948693322995\ \(0\)\
\-\ developing\\:\\ 0\\.008501355517324742\ \(0\)\
\-\ remains\\:\\ 0\\.008452605649238549\ \(0\)\
\-\ experienced\\:\\ 0\\.008428691614624746\ \(0\)\
\-\ complicated\\:\\ 0\\.008428691614624746\ \(0\)\
\-\ am\\:\\ 0\\.008358703072566349\ \(0\)\
\-\ prior\\:\\ 0\\.008342634114837884\ \(0\)\
\-\ factor\\:\\ 0\\.008291199862572225\ \(0\)\
\-\ determine\\:\\ 0\\.008226011509951251\ \(0\)\
\-\ date\\:\\ 0\\.008162984499843077\ \(0\)\
\-\ to\\:\\ 0\\.008119165559752591\ \(0\)\
\-\ d\\:\\ 0\\.008101980099555052\ \(0\)\
\-\ concern\\:\\ 0\\.008082072685358674\ \(0\)\
\-\ characterized\\:\\ 0\\.008082072685358674\ \(0\)\
\-\ earlier\\:\\ 0\\.00802357143314051\ \(0\)\
\-\ in\\:\\ 0\\.00801135418517595\ \(0\)\
\-\ simple\\:\\ 0\\.008004464330757426\ \(0\)\
\-\ six\\:\\ 0\\.007985547351949123\ \(0\)\
\-\ complication\\:\\ 0\\.00796681675034644\ \(0\)\
\-\ uncommon\\:\\ 0\\.007948268889233579\ \(0\)\
\-\ asymmetric\\:\\ 0\\.007893686938886752\ \(0\)\
\-\ bilateral\\:\\ 0\\.00788523851450359\ \(0\)\
\-\ sonographic\\:\\ 0\\.00787583572149162\ \(0\)\
\-\ felt\\:\\ 0\\.007642068209828435\ \(0\)\
\-\ discussion\\:\\ 0\\.007610901271091408\ \(0\)\
\-\ lipoma\\:\\ 0\\.007595507335287949\ \(0\)\
\-\ a\\:\\ 0\\.007539920186665423\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.007405964825358124\ \(0\)\
\-\ l\\:\\ 0\\.007405964825358124\ \(0\)\
\-\ incidentally\\:\\ 0\\.007364783272542194\ \(0\)\
\-\ j\\:\\ 0\\.007337816285865471\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.00731122647222528\ \(0\)\
\-\ left\\:\\ 0\\.007270762503976538\ \(0\)\
\-\ clinically\\:\\ 0\\.0071228407257533585\ \(0\)\
\-\ under\\:\\ 0\\.0070990761577605236\ \(0\)\
\-\ recurrence\\:\\ 0\\.00708730435120554\ \(0\)\
\-\ addition\\:\\ 0\\.006886999188357962\ \(0\)\
\-\ \\(\\:\\ 0\\.006866556333116545\ \(0\)\
\-\ adenoma\\:\\ 0\\.006784209794308008\ \(0\)\
\-\ \\)\\:\\ 0\\.0067826776816854095\ \(0\)\
\-\ references\\:\\ 0\\.006754426302398503\ \(0\)\
\-\ recommended\\:\\ 0\\.006734826740309414\ \(0\)\
\-\ especially\\:\\ 0\\.006686694025510383\ \(0\)\
\-\ pathology\\:\\ 0\\.006649046445099395\ \(0\)\
\-\ treatment\\:\\ 0\\.0065764903406877835\ \(0\)\
\-\ 25\\:\\ 0\\.006566970072732077\ \(0\)\
\-\ includes\\:\\ 0\\.006549202273457862\ \(0\)\
\-\ 4\\.\\:\\ 0\\.006396349753613684\ \(0\)\
\-\ result\\:\\ 0\\.006232289271764186\ \(0\)\
\-\ referred\\:\\ 0\\.006130287915314907\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.006067492239123878\ \(0\)\
\-\ studies\\:\\ 0\\.006067492239123878\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.00603348165974978\ \(0\)\
\-\ could\\:\\ 0\\.005993456166978236\ \(0\)\
\-\ palpable\\:\\ 0\\.005757834681748651\ \(0\)\
\-\ being\\:\\ 0\\.005661193872244408\ \(0\)\
\-\ 3\\.\\:\\ 0\\.005558696220799862\ \(0\)\
\-\ cause\\:\\ 0\\.005496697008653928\ \(0\)\
\-\ 10\\:\\ 0\\.005476471917009335\ \(0\)\
\-\ followed\\:\\ 0\\.005446532074864585\ \(0\)\
\-\ cases\\:\\ 0\\.0054121879543367534\ \(0\)\
\-\ cancer\\:\\ 0\\.005340618373317044\ \(0\)\
\-\ 2\\.\\:\\ 0\\.005166243615589845\ \(0\)\
\-\ day\\:\\ 0\\.005157718306754619\ \(0\)\
\-\ found\\:\\ 0\\.00511982055979489\ \(0\)\
\-\ while\\:\\ 0\\.005111500455992991\ \(0\)\
\-\ 1\\.\\:\\ 0\\.005074504118436503\ \(0\)\
\-\ resection\\:\\ 0\\.005066379573232355\ \(0\)\
\-\ clinical\\:\\ 0\\.004998687832825103\ \(0\)\
\-\ diffuse\\:\\ 0\\.0049182650577477465\ \(0\)\
\-\ patient\\:\\ 0\\.004885505309409057\ \(0\)\
\-\ her\\:\\ 0\\.004884813038944744\ \(0\)\
\-\ ultrasound\\:\\ 0\\.00481962468632377\ \(0\)\
\-\ years\\:\\ 0\\.004770424214864035\ \(0\)\
\-\ likely\\:\\ 0\\.004582300315467028\ \(0\)\
\-\ performed\\:\\ 0\\.004529616599291481\ \(0\)\
\-\ 4\\:\\ 0\\.0045265625573746105\ \(0\)\
\-\ however\\:\\ 0\\.0045235134136826435\ \(0\)\
\-\ been\\:\\ 0\\.004419762147269945\ \(0\)\
\-\ up\\:\\ 0\\.00436853070542628\ \(0\)\
\-\ cm\\:\\ 0\\.004357331022465752\ \(0\)\
\-\ for\\:\\ 0\\.004158411494159972\ \(0\)\
\-\ more\\:\\ 0\\.004063072831391951\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.003992652162798131\ \(0\)\
\-\ surgery\\:\\ 0\\.003944865141369344\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.003915873577913009\ \(0\)\
\-\ 1\\:\\ 0\\.0038656394828131308\ \(0\)\
\-\ without\\:\\ 0\\.0038251200881333843\ \(0\)\
\-\ imaging\\:\\ 0\\.0038062240008661648\ \(0\)\
\-\ 3\\:\\ 0\\.0038041359823318245\ \(0\)\
\-\ \\%\\:\\ 0\\.0037895837135855657\ \(0\)\
\-\ tumor\\:\\ 0\\.003787513881389375\ \(0\)\
\-\ of\\:\\ 0\\.0037653319649539984\ \(0\)\
\-\ was\\:\\ 0\\.0037577092099379725\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003730455001483688\ \(0\)\
\-\ this\\:\\ 0\\.0036545141190651447\ \(0\)\
\-\ it\\:\\ 0\\.0036518030124201837\ \(0\)\
\-\ have\\:\\ 0\\.003517943114762532\ \(0\)\
\-\ 2\\:\\ 0\\.003498297521883168\ \(0\)\
\-\ after\\:\\ 0\\.003361219016367305\ \(0\)\
\-\ female\\:\\ 0\\.0033398484248057672\ \(0\)\
\-\ presents\\:\\ 0\\.0033187153906994787\ \(0\)\
\-\ has\\:\\ 0\\.0030507604001792357\ \(0\)\
\-\ that\\:\\ 0\\.002806047012469246\ \(0\)\
\-\ by\\:\\ 0\\.0027050777628229556\ \(0\)\
\-\ disease\\:\\ 0\\.0026553945650488672\ \(0\)\
\-\ the\\:\\ 0\\.0026283133974073346\ \(0\)\
\-\ there\\:\\ 0\\.0024177101833935148\ \(0\)\
\-\ not\\:\\ 0\\.0023475640147185084\ \(0\)\
\-\ history\\:\\ 0\\.0022437538739678393\ \(0\)\
\-\ \\.\\:\\ 0\\.002159667595275819\ \(0\)\
\-\ and\\:\\ 0\\.0017111122217891488\ \(0\)\
\-\ no\\:\\ 0\\.0016358253815661635\ \(0\)\
\-\ on\\:\\ 0\\.0013762186546871257\ \(0\)\
\-\ with\\:\\ 0\\.000889765597641747\ \(0\)\
